Published: 2023-09-19 Diamond Biofund Takes Off: Biotech in Acceleration Diamond Biofund (TWSE: 6901) joined the Taiwan Stock Exchange Mainboard on September 19, 2023 as the first public evergreen venture capital dedicated to biotech investments. This milestone event in Taiwan’s capital market aims to inspire more evergreen venture capital funds to invest in emerging and innovative...Read More

Published: 2022-02-21 Microbio Group (TPEx : 4128 ) announced this ( 21 ) evening that its subsidiary Oneness Biotech and Microbio Shanghai, its subsidiary in China, have developed the world’s first and only broad-spectrum Covid drug SNS812 . The published experimental data shows that the new small nucleic acid drug SNS812 directly locks the important...Read More

On the 27th, Oneness Biotech( TPEx : 4743 ) announced that it completed the pricing of the issuance of Global Depositary Receipt (GDR ), with a total overseas fundraising amount of approximately US$ 177 million (approximately NT$ 5.06 billion). Oneness said that this GDR distribution not only is the first international capital market issuance since Oneness became listed on the TPEx in 2011 , but also successfully set the following...Read More

Published: 2020-04-16 Oneness Biotech announced yesterday (15th) that it has reached a licensing agreement with Denmark’s LEO Pharma with regard to the new antibody drug technology FB825 which was developed by Oneness and licensed amounted US$530 million (approximately NT$16 billion). Oneness mentioned that phase II a (2a) clinical trial for atopic dermatitis will be implemented in the U.S. and expected to...Read More